{"id":"W2125665528","doi":"10.1200/jco.2015.62.1342","title":"Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":851,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Pemetrexed; Oncology; Gefitinib; Erlotinib; Internal medicine; Crizotinib; Docetaxel; Lung cancer; Carboplatin; Afatinib; Chemotherapy; Bevacizumab; Cancer; Epidermal growth factor receptor; Malignant pleural effusion; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007163749,0.001204111,0.002467314,0.00410662,0.0008858463,0.00214594,0.003677698,0.004062608,0.0070502],"category_scores_gemma":[0.02307389,0.0006518963,0.00384883,0.005361419,0.0007012115,0.002280446,0.001827965,0.005433438,0.005192528],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004304858,"about_ca_system_score_gemma":0.01554605,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02128155,"about_ca_topic_score_gemma":0.04602343,"domain_scores_codex":[0.9927819,0.0023332,0.001921668,0.0003488676,0.002317649,0.0002968232],"domain_scores_gemma":[0.9813488,0.00372519,0.00275096,0.0003501712,0.01094936,0.0008754997],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005241246,0.0001054839,0.00102085,0.01195532,0.0002759293,0.0001517416,0.0001788375,0.0006583161,0.0002570355,0.002067242,0.6990719,0.284205],"study_design_scores_gemma":[0.0002747593,0.00008418178,0.003083523,0.04767641,0.0008462252,0.0006271396,0.0001535441,0.0005869434,0.0001982178,0.003578243,0.9428328,0.00005806641],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"editorial","genre_scores_codex":[0.003172264,0.6189299,0.01688035,0.2342659,0.01373299,0.006907585,0.01847011,0.001002372,0.08663854],"genre_scores_gemma":[0.01372425,0.7605954,0.08093909,0.07551815,0.006024716,0.00821307,0.03728178,0.0003329264,0.01737052],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.02128155,"threshold_uncertainty_score":0.04231536,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.197713970446764,"score_gpt":0.6016853804165807,"score_spread":0.4039714099698167,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}